Cholestyramine how supplied storage and handling

Revision as of 16:46, 10 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Cholestyramine}} {{CMG}}; {{AE}} {{SS}} ==How Supplied Storage and Handling== Prevalite® (Cholestyramine for Oral Suspension, USP) available in cartons of forty-...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cholestyramine
PREVALITE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Cholestyramine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied Storage and Handling

Prevalite® (Cholestyramine for Oral Suspension, USP) available in cartons of forty-two and sixty single-dose packets and in cans containing 231 grams. 5.5 grams of Prevalite® contain 4 grams of anhydrous cholestyramine resin.

NDC 0245-0036-42 Cartons of 42, 5.5 g packets

NDC 0245-0036-60 Cartons of 60, 5.5 g packets

NDC 0245-0036-23 Cans, 231 g (42 doses)

Store at controlled room temperature, 15-30°C (59-86°F).

Rx only.[1]


References

  1. "PREVALITE (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [UPSHER-SMITH LABORATORIES INC.]". Retrieved 10 February 2014.

Template:Lipid modifying agents